Encompass Design shares list at 90% premium over IPO price on NSE SME platformEncompass Design India, operating ScaleSauce, made a strong market debut, listing at a 90% premium despite a zero GMP ahead of its IPO. The...
12 Dec, 2025, 11.02 AM IST
Vidya Wires IPO Day 2: GMP trends, strong subscription. Should you apply?Vidya Wires IPO: In the grey market, the IPO is quoting a ₹5 premium — about 9.6% above the upper price band — suggesting a possible listin...
04 Dec, 2025, 10.22 AM IST
Meesho IPO: How the women-powered platform left Amazon and Flipkart chasing discountsMeesho has emerged as India’s largest e-commerce marketplace by tapping millions of value-conscious shoppers in small towns. Built on low p...
01 Dec, 2025, 11.21 AM IST
As Nifty & Sensex recover, these large-caps have ‘strong buy’, ‘buy’ recos, with an upside potential of more than 28%There’s this old saying in the stock market: Even when the bulls are in control, you can never write off the bears. They have and will make...
13 Oct, 2025, 11.33 PM IST
Canara HSBC Life Insurance IPO Day 2: Check GMP, subscription status, and key details. Should you apply?Canara HSBC Life Insurance IPO: The grey market premium (GMP) for Canara HSBC Life shares has fallen from Rs 10 to Rs 2, with the IPO price...
13 Oct, 2025, 10.54 AM IST
Canara Robeco AMC IPO Day 2: Issue subscribed 48%. Check GMP, other detailsCanara Robeco AMC IPO Day 2: As of October 10, 2025, the Canara Robeco IPO has a Grey Market Premium of ₹20, implying a projected listing p...
10 Oct, 2025, 06.50 PM IST
Netweb Technologies shares more than double in 3 months. Should you buy, sell or hold?Netweb Technologies shares are soaring, driven by strong demand for its artificial intelligence and cloud infrastructure solutions. The com...
07 Oct, 2025, 11.06 AM IST
Retail investors hit hard: 8 of top 10 most held stocks in redData from the quarter reveals a worrying trend: most retail-favourite stocks have delivered negative returns despite their popularity. Howe...
09 Sep, 2025, 04.16 PM IST
NSDL IPO GMP hints at 17% listing gains, but pre-IPO investors still nursing lossesNSDL’s IPO, priced 22% below its last unlisted valuation, stirred mixed reactions—pre-IPO investors face notional losses, while public inve...
02 Aug, 2025, 11.00 AM IST
After bumper response for IPO, MobiKwik gears up for strong debut. Check GMP and listing dateMobiKwik's IPO saw overwhelming demand, with a 125-times subscription driven by retail investors, who subscribed 141.78 times their allocat...
16 Dec, 2024, 02.56 PM IST
Mukul Agrawal buys 1.58% stake in Stanley Lifestyle, stock up 7%BSE data reveals that Mukul Mahavir Agrawal holds nearly 9 lakh shares in the company. As of September 2024, Stanley Lifestyle’s equity str...
21 Oct, 2024, 02.20 PM IST
Responsible Innovation, how a blueprint for collaborative action is advancing global healthcareOn the occasion of the Abu Dhabi Global Healthcare Week (ADGHW), Dr. Asma Ibrahim Al Mannaei, Executive Director of the Research and Innova...
20 May, 2024, 05.39 PM IST
Will Data Patterns deliver a listing pop? Here's what grey market saysA few hours ahead of listing, Data Patterns was commanding a premium of Rs 320-325 or 55 per cent in the unofficial market, over its issue ...
23 Dec, 2021, 07.03 PM IST
Top drug makers like Sun Pharma, Torrent, Cipla working on quality standards at manufacturing facilitiesArch rivals are grouping to look for a lasting solution to what external subject experts call “deeply ingrained culture issue”.
20 Feb, 2016, 06.19 AM IST
Daiichi Sankyo attempts to restore Ranbaxy’s credibility, but difficult road ahead“Troubles of the past should not trouble us in the future,” says a determined Arun Sawhney, Ranbaxy's managing director since 2009.
04 Aug, 2013, 06.54 AM IST
- Industry
The year 2004-05 started on a positive note in April 2004 with annual growth of 8.9 per cent in the Index of Industrial Production.
25 Feb, 2005, 11.24 PM IST